Corcept Therapeutics Incorporated (0I3Q)
Market Closed
24 Feb, 15:30
LSE 
$
36. 73
+1.61
+4.59%
$
5.86B Market Cap
- P/E Ratio
- Div Yield
926 Volume
- Eps
$ 35.12
Previous Close Day Range
35.34 37.4
Year Range
20.76 37.4
Want to track 0I3Q and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0I3Q earnings report is expected in 68 days (4 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.33 | - |
| | | 0.33 | - |
| | | - | - |
| | | - | - |
| | | - | - |
0I3Q Earnings Reports FAQ
What is the earnings per share (EPS) for 0I3Q?
EPS data for 0I3Q is currently not available, as Corcept Therapeutics Incorporated has not reported recent earnings.
What is the company's earnings growth rate?
Corcept Therapeutics Incorporated has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-25, based on the 0I3Q's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Corcept Therapeutics Incorporated are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0I3Q at this time, as Corcept Therapeutics Incorporated has no recent EPS data to calculate it.
